Atlas Trials

BONE: STAR (Switching to TAF Based Anti-Retroviral Therapy) Study

Clinical trial NCT03916328 · UNKNOWN

Trial details

NCT number
NCT03916328
Sponsor
MU-JHU CARE
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Bone Loss
Start date
2019-12-03
Primary completion
2024-03-31
Enrollment
330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.